Atea Pharma Says FDA Grants Fast Track Designation To AT-752 For Treatment Of Dengue

RTTNews | 1056 days ago
Atea Pharma Says FDA Grants Fast Track Designation To AT-752 For Treatment Of Dengue

(RTTNews) - Biopharmaceutical company Atea Pharmaceuticals, Inc. (AVIR) announced Monday that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to AT-752, a novel, orally administered, direct-acting antiviral for the treatment of dengue virus infection.

AT-752, a novel, orally administered direct-acting antiviral derived from Atea's purine nucleotide prodrug platform was designed for the treatment and prophylaxis of dengue. It works by impairing the dengue viral polymerase, which then inhibits replication of the virus.

AT-752 is in Phase 2 clinical development and was generally well tolerated in a Phase 1 clinical study. In preclinical studies, AT-752 showed potent in vitro activity against all dengue serotypes, as well as potent in vivo antiviral activity in a small animal model.

For More Such Health News, visit rttnews.com

read more
Atea Pharma Rejects Unsolicited Proposal From Tang Capital Partners

Atea Pharma Rejects Unsolicited Proposal From Tang Capital Partners

Biopharmaceutical company Atea Pharmaceuticals, Inc. (AVIR) announced Tuesday that its Board of Directors unanimously rejected the unsolicited proposal from Tang Capital Partners, LP on behalf of Concentra Biosciences, LLC to acquire all outstanding common shares of Atea for $5.75 per share in cash, plus a contingent value right representing the right to receive 80% of the net proceeds payable from any license or disposition of Atea's programs.
RTTNews | 810 days ago
Lower Open Predicted For Taiwan Stock Market

Lower Open Predicted For Taiwan Stock Market

The Taiwan stock market rebounded on Friday, one day after ending the five-day winning streak in which it had rallied more than 910 points or 3.9 percent. The Taiwan Stock Exchange now sits just above the 24,330-point plateau although it may head south again on Monday.
RTTNews | 20 minutes ago
Little Movement Expected For Singapore Stock Market

Little Movement Expected For Singapore Stock Market

The Singapore stock market has moved lower in two straight sessions, falling more than 40 points or 0.9 percent along the way. The Straits Times Index now sits just above the 4,230-point plateau and it's likely to remain in that neighborhood again on Monday.
RTTNews | 50 minutes ago
Malaysia Bourse Likely To Remain Rangebound On Monday

Malaysia Bourse Likely To Remain Rangebound On Monday

The Malaysia stock market has moved lower in back-to-back sessions, slipping more than 10 points or 0.6 percent along the way. The Kuala Lumpur Composite Index now sits just above the 1,575-point plateau and it may tick lower again on Monday.
RTTNews | 1h 20min ago
Japan Shares Due For Profit Taking On Monday

Japan Shares Due For Profit Taking On Monday

The Japan stock market bounced higher again on Friday, one day after snapping the six-day winning streak in which it had surged more than 3,000 points or 7.3 percent. The Nikkei 225 now sits just beneath the 43,380-point plateau although investors are likely to lock in gains on Monday.
RTTNews | 1h 35min ago
South Korea Shares May Be Stuck In Neutral On Monday

South Korea Shares May Be Stuck In Neutral On Monday

Ahead of Friday's holiday for Liberation Day, the South Korea stock market had moved higher in back-to-back sessions, gathering more than 35 points or 1.1 percent along the way. The KOSPI now sits just above the 3,225-point plateau although it m ay spin its wheels on Monday.
RTTNews | 1h 50min ago
Singapore Export Data On Tap For Monday

Singapore Export Data On Tap For Monday

Singapore will on Monday release July figures for non-oil domestic exports, highlighting a light day for Asia-Pacific economic activity. In June, NODX was up 14.3 percent on month and 13.0 percent on year.
RTTNews | 2h 50min ago